Otilimab
Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor[1].
Product Specifications
CAS Number
1638332-55-4
Product Name Alternative
GSK 3196165; MOR103
UNSPSC
12352203
Target
C-Fms
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/otilimab.html
Purity
99.29
Solubility
10 mM in DMSO
Smiles
[Otilimab]
Molecular Weight
(142.22 kDa)
References & Citations
[1]Senolt L. Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies. F1000Res. 2019 Aug 30;8:F1000 Faculty Rev-1549.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Ly2885-500gEcoli 500 µg (E. coli)
Recombinant Campylobacter Jejuni rplQ Protein (aa 1-117) (strain RM1221)
Sign In for Pricing
View Details 
042630-FITC 200 µL
TBC1D2, ID (TBC1D2, PARIS1, PP8997, TBC1D2A, TBC1 domain family member 2A, Armus, Prostate antigen recognized and identified by SEREX 1) (FITC) discontinued
Sign In for Pricing
View Details 
42130061 1.0 µg DNA
RPS15AP31 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details